Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New and future immunomodulatory therapy in type 1 diabetes.
Tooley JE, Waldron-Lynch F, Herold KC. Tooley JE, et al. Trends Mol Med. 2012 Mar;18(3):173-81. doi: 10.1016/j.molmed.2012.01.001. Epub 2012 Feb 17. Trends Mol Med. 2012. PMID: 22342807 Free PMC article. Review.
Continuous glucose monitoring: long live the revolution!
Waldron-Lynch F, Herold KC. Waldron-Lynch F, et al. Nat Clin Pract Endocrinol Metab. 2009 Feb;5(2):82-3. doi: 10.1038/ncpendmet1044. Epub 2008 Dec 17. Nat Clin Pract Endocrinol Metab. 2009. PMID: 19092785 No abstract available.
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.
Herold KC, Gitelman SE, Willi SM, Gottlieb PA, Waldron-Lynch F, Devine L, Sherr J, Rosenthal SM, Adi S, Jalaludin MY, Michels AW, Dziura J, Bluestone JA. Herold KC, et al. Diabetologia. 2013 Feb;56(2):391-400. doi: 10.1007/s00125-012-2753-4. Epub 2012 Oct 21. Diabetologia. 2013. PMID: 23086558 Free PMC article. Clinical Trial.
Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D).
Heywood J, Evangelou M, Goymer D, Kennet J, Anselmiova K, Guy C, O'Brien C, Nutland S, Brown J, Walker NM, Todd JA, Waldron-Lynch F. Heywood J, et al. Trials. 2015 Mar 11;16:86. doi: 10.1186/s13063-015-0583-7. Trials. 2015. PMID: 25881192 Free PMC article. Clinical Trial.
38 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page